Generics

Innovative Products found!

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-097 manufacturers

Filters

None products found

pp-097

Gel

Dossier type
CTD
Dossier status
Under development
Country of origin
Israel
Comments
Indication: Prevention of new basal cell carcinoma (BCC) lesions in adults with Gorlin syndrome, a rare genetic condition with high propensity for BCC formation Clinical stage: Late clinical development — Phase 3 global clinical trial underway with top‑line results anticipated in late 2026 Modality: Small molecule, topical gel formulation Mechanism / Target: Hedgehog signaling pathway blocker targeting the SMO receptor to reduce aberrant pathway activity driving BCC lesion formation Route / form: Topical administration; 2% gel formulation intended for chronic use on the skin Differentiation: First‑in‑class topical hedgehog pathway inhibitor designed specifically for BCC prevention with minimal systemic adverse effects compared with oral hedgehog inhibitors
Manufacturer #38928

Clinical-stage biotechnology company developing targeted topical therapies for rare dermatologic conditions. Focuses on hedgehog pathway inhibitors to prevent basal cell carcinoma lesions. Strategy emphasizes global clinical trials and future commercialization partnerships.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.